Xtant Medical Holdings, Inc. (NYSE American: XTNT) Delivers Strong Q4 and Full-Year 2025 ResultsXtant Medical Holdings, Inc., a medical technology company specializing in biologics and surgical solutions for spinal and orthopedic conditions, reported solid financial performance for the fourth quarter and full year 2025 on March 31, 2026.The company achieved full-year 2025 revenue of $133.9 million, representing a robust 14% increase compared to 2024. In the fourth quarter, revenue reached $32.4 million, up ...